Skip to content

Towards a shortened sick leave duration of employees sick-listed due to common mental disorders

Effectiveness of the guideline ?management of workers with common mental health problems by occupational physicians?: a randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN86605310
Enrollment
232
Registered
2010-08-11
Start date
2010-10-15
Completion date
Unknown
Last updated
2016-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sick leave due to common mental disorders Mental and Behavioural Disorders

Interventions

OPs in the experimental condition are trained in the Dutch guideline 'management of workers with common mental health problems by occupational physicians'. OPs will be divided into groups of 6 - 10 OP

Sponsors

Netherlands Organisation for Health Research and Development (ZonMw) (Netherlands)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. A common mental disorder, i.e. anxiety, depression, burnout or emotional distress, is the primary reason for sick leave at the time of inclusion. Physical problems may be present, but should not cause absenteeism 2. Dutch speaking 3. Counseled by an OP that takes part in the study

Exclusion criteria

Exclusion criteria: 1. Acute crisis or suicidality 2. Sick leave duration of less than 4 weeks, as a quick recovery of part of this group may dilute the statistical power of the study 3. Sick leave duration of more than 8 weeks, as the study aims to prevent long term sick leave

Design outcomes

Primary

MeasureTime frame
Time to full return to work, defined as the number of days between the first day of sickness absence and the first day of full return to work

Secondary

MeasureTime frame
1. Partial return to work 2. Total days of sick leave at 12 months 3. Patient satisfaction, assessed by a short questionnaire developed for this study 4. Symptoms, measured using the 4DSQ (Terluin 2002) Outcomes will be assessed at baseline, 3, 6 and 12 months.

Countries

Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 24, 2026